LIVAGEN 20mg

Livagen is a synthetic tetrapeptide (Lys-Glu-Asp-Ala) developed in Russia. It is classified as an organ-specific peptide bioregulator studied for its ability to decondense chromatin, which may allow aging cells to reactivate silenced genes and improve protein synthesis.Key CharacteristicsMechanism of Action: Research suggests it binds to DNA and unpacks heterochromatin, helping cells maintain a more youthful gene expression profile.Tissue Focus: Studies—primarily in vitro and in animal models—indicate its primary effects are in lymphocytes (immune cells), the liver, and the gastrointestinal tract.Enzyme Inhibition: Livagen has been shown to inhibit certain enkephalin-degrading enzymes in human blood serum, which could play a role in pain and immune regulation.Status: It is not approved for human consumption or therapeutic use. It is widely sold online strictly as a chemical for in-vitro scientific research.Scientific ContextLivagen was originally synthesized in the late 1990s as part of a group of short peptides (including Epitalon and Cortagen) developed by Vladimir Khavinson. Early research from Khavinson’s team suggested that it could stimulate the activity of ribosomal genes repressed by age-related chromatin condensation.For further reading on its preclinical mechanisms and ongoing research, you can explore the Wikipedia Livagen Entry or review specific findings in the PubMed Livagen Digestive Enzymes Study. Livagen – WikipediaTable_title: Livagen Table_content: | Identifiers | | | — | — | | ChemSpider | 57489559 | | Chemical and physical data | | | Formula | C18H31N5O9 | | Molar …Wikipedia